Cytosorbents Corporation (CTSO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cytosorbents Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.017 Good afternoon, ladies and gentlemen, and welcome to the Cytosorbent's first quarter 00:00:04.017 -- 00:00:09.865 2025 earnings conference call. At this time, all lines are in listen only mode. 00:00:09.865 -- 00:00:14.232 Following the presentation, we will conduct a question and answer session. 00:00:14.232 -- 00:00:18.818 If at any time during this call you require immediate assistance, please press star zero 00:00:18.818 -- 00:00:23.946 for the operator. This call is being recorded on Thursday, May 8th, front bearing 00:00:23.946 -- 00:00:26.690 five. I would now like to turn the conference over to Mr. 00:00:26.690 -- 00:00:29.360 Dan Alexander. Please go ahead. 00:00:29.360 -- 00:00:31.823 Thank you, Constantine, and good afternoon, everyone. 00:00:31.823 -- 00:00:36.569 Welcome to SIDUS Auburn's first quarter 2025 financial results and recent business highlights 00:00:36.569 -- 00:00:40.954 conference call. Joining me today from the company for prepared remarks are Dr. 00:00:40.954 -- 00:00:46.400 Philip Chan, Chief Executive Officer, Dr. Micah Delia-Garris, Chief Medical Officer, 00:00:46.400 -- 00:00:50.044 and Pete Mariani, Chief Financial Officer. 00:00:50.044 -- 00:00:53.649 Before I turn the call over to Dr. Chan, I'd like to remind listeners that during the 00:00:53.649 -- 00:00:57.373 call, management's prepared remarks may contain forward-looking statements which are 00:00:57.373 -- 00:01:00.038 subject to risks and uncertainties. 00:01:00.038 -- 00:01:03.763 Management may make additional forward-looking statements in response to your questions 00:01:03.763 -- 00:01:08.470 today. Therefore, the company claims protection under the safe harbor for forward-looking 00:01:08.470 -- 00:01:13.394 statements contained in th...